Northcape Wealth Management LLC Increases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Northcape Wealth Management LLC raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 4,345 shares of the healthcare conglomerate’s stock after acquiring an additional 37 shares during the period. Northcape Wealth Management LLC’s holdings in UnitedHealth Group were worth $2,198,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Atlas Legacy Advisors LLC purchased a new position in UnitedHealth Group in the fourth quarter valued at approximately $1,090,000. Bank of Jackson Hole Trust purchased a new position in shares of UnitedHealth Group in the 4th quarter valued at $1,371,000. Callahan Advisors LLC boosted its position in UnitedHealth Group by 0.6% during the 4th quarter. Callahan Advisors LLC now owns 43,835 shares of the healthcare conglomerate’s stock worth $22,174,000 after purchasing an additional 266 shares during the period. Mcdonald Partners LLC raised its position in UnitedHealth Group by 4.0% in the fourth quarter. Mcdonald Partners LLC now owns 2,826 shares of the healthcare conglomerate’s stock valued at $1,430,000 after purchasing an additional 109 shares during the period. Finally, Davidson Investment Advisors purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth about $9,539,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently commented on UNH shares. Deutsche Bank Aktiengesellschaft boosted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Wells Fargo & Company lowered their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Finally, Oppenheimer lifted their price objective on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a report on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $629.32.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $501.52 on Wednesday. The stock has a market capitalization of $461.54 billion, a P/E ratio of 32.36, a P/E/G ratio of 1.43 and a beta of 0.61. The firm’s 50-day moving average price is $521.08 and its two-hundred day moving average price is $562.03. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the prior year, the business earned $5.83 EPS. The firm’s revenue was up 6.8% on a year-over-year basis. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.